Fenteany Gabriel, Sharma Gaurav, Gaur Paras, Borics Attila, Wéber Edit, Kiss Ernő, Haracska Lajos
Institute of Genetics, Biological Research Centre, 6726 Szeged, Hungary.
HCEMM-BRC Mutagenesis and Carcinogenesis Research Group, Institute of Genetics, Biological Research Centre, 6726 Szeged, Hungary.
iScience. 2022 Mar 10;25(4):104053. doi: 10.1016/j.isci.2022.104053. eCollection 2022 Apr 15.
Ubiquitination of proliferating cell nuclear antigen (PCNA) triggers pathways of DNA damage tolerance, including mutagenic translesion DNA synthesis, and comprises a cascade of reactions involving the E1 ubiquitin-activating enzyme Uba1, the E2 ubiquitin-conjugating enzyme Rad6, and the E3 ubiquitin ligase Rad18. We report here the discovery of a series of xanthenes that inhibit PCNA ubiquitination, Rad6∼ubiquitin thioester formation, and the Rad6-Rad18 interaction. Structure-activity relationship experiments across multiple assays reveal chemical and structural features important for different activities along the pathway to PCNA ubiquitination. The compounds that inhibit these processes are all a subset of the xanthen-3-ones we tested. These small molecules thus represent first-in-class probes of Rad6 function and the association of Rad6 and Rad18, the latter being a new inhibitory activity discovered for a small molecule, in the PCNA ubiquitination cascade and potential therapeutic agents to contain cancer progression.
增殖细胞核抗原(PCNA)的泛素化会触发DNA损伤耐受途径,包括诱变跨损伤DNA合成,且这一过程包含一系列反应,涉及E1泛素激活酶Uba1、E2泛素结合酶Rad6和E3泛素连接酶Rad18。我们在此报告了一系列呫吨类化合物的发现,这些化合物可抑制PCNA泛素化、Rad6~泛素硫酯的形成以及Rad6与Rad18的相互作用。通过多种实验进行的构效关系研究揭示了在PCNA泛素化途径中对不同活性至关重要的化学和结构特征。抑制这些过程的化合物均为我们所测试的呫吨-3-酮的一个子集。因此,这些小分子代表了Rad6功能以及Rad6与Rad18相互作用的一类新型探针,后者是在PCNA泛素化级联反应中发现的一种小分子新抑制活性,并且是潜在的抑制癌症进展的治疗药物。